Clinical trials
Phase 1/2 Lymphoma, Non-Hodgkin trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 5 |
| 2021 | 2 |
| 2022 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Active, not recruiting | 5 |
| Terminated | 5 |
| Recruiting | 4 |
| Unknown status | 3 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 5 |
| Merck Sharp & Dohme LLC | 2 |
| AbbVie (prior sponsor, Abbott) | 1 |
| Accenture | 1 |
| Acerta Pharma BV | 1 |
| BeOne Medicines | 1 |
| Bristol-Myers Squibb | 1 |
| CRISPR Therapeutics AG | 1 |
| Celgene | 1 |
| Ciusss de L'Est de l'Île de Montréal | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Non-Hodgkin | 28 |
| Hodgkin Disease | 7 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 6 |
| Lymphoma, Follicular | 6 |
| Lymphoma, B-Cell | 5 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
| Hematologic Neoplasms | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Recurrence | 4 |
| Lymphoma | 3 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.